Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalibor Valik

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Chemistry|February 4, 2006
Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisitedJaroslav Sterba, Ladislav Dusek, Regina Demlova, et al.
International Journal of Molecular Sciences|September 12, 2020
Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-<i>Trans</i> Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell LinesSilvia Paukovcekova, Dalibor Valik, Jaroslav Sterba, et al.
Pharmacogenomics|December 9, 2004
Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapyDalibor Valik, Martin Radina, Jaroslav Sterba, et al.
Oncology|September 17, 2005
Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folateDalibor Valik, Jaroslav Sterba, Viera Bajciova, et al.
Journal of Cellular Biochemistry|April 23, 2002
Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosisMichael A Sheard, Borek Vojtesek, Marta Simickova, et al.
Frontiers in Cardiovascular Medicine|September 15, 2023
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the futureEva Rihackova, Michal Rihacek, Maria Vyskocilova, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2018
Host-dependent variables: The missing link to personalized medicineRegina Demlova, Lenka Zdrazilova-Dubska, Jaroslav Sterba, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2018
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatmentKaterina Pilatova, Beatrix Bencsikova, Regina Demlova, et al.
Journal of Medical Virology|October 20, 2020
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMIIveta Selingerova, Dalibor Valik, Lenka Gescheidtova, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer PatientsMichal Rihacek, Iveta Selingerova, Ivo Kocak, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Chemistry|February 4, 2006
Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisitedJaroslav Sterba, Ladislav Dusek, Regina Demlova, et al.
International Journal of Molecular Sciences|September 12, 2020
Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-<i>Trans</i> Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell LinesSilvia Paukovcekova, Dalibor Valik, Jaroslav Sterba, et al.
Pharmacogenomics|December 9, 2004
Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapyDalibor Valik, Martin Radina, Jaroslav Sterba, et al.
Oncology|September 17, 2005
Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folateDalibor Valik, Jaroslav Sterba, Viera Bajciova, et al.
Journal of Cellular Biochemistry|April 23, 2002
Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosisMichael A Sheard, Borek Vojtesek, Marta Simickova, et al.
Frontiers in Cardiovascular Medicine|September 15, 2023
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the futureEva Rihackova, Michal Rihacek, Maria Vyskocilova, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2018
Host-dependent variables: The missing link to personalized medicineRegina Demlova, Lenka Zdrazilova-Dubska, Jaroslav Sterba, et al.
Cancer Immunology, Immunotherapy : CII|May 12, 2018
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatmentKaterina Pilatova, Beatrix Bencsikova, Regina Demlova, et al.
Journal of Medical Virology|October 20, 2020
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMIIveta Selingerova, Dalibor Valik, Lenka Gescheidtova, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer PatientsMichal Rihacek, Iveta Selingerova, Ivo Kocak, et al.
Pageof 5